DEVELOPMENT AND INNOVATION IN CANCER MEDICINE

Karol Sikora
Additional contact information
Karol Sikora: Buckingham School of Medicine, The University of Buckingham, Hunter Street, Buckingham MK18 1EG, UK

Chapter 3 in Innovation in the Biopharmaceutical Industry, 2007, pp 45-64 from World Scientific Publishing Co. Pte. Ltd.

Abstract: AbstractGreat strides have been made in the field of cancer medicine towards understanding the fundamental biology of cancers. Impressive treatments have emerged, resulting in markedly prolonged survival for many patients. These advances mean that, within the next 20 years, cancer could become a chronic disease rather than a death warrant. But that promise depends on sustained investment in innovation, and on society's willingness to pay for that innovation.Realising this promise might be a problem for Europe where investment in medical science remains low compared to the United States which is driving global innovation in cancer technology (providing 55% of global funding for cancer although it only has 5% of the global cancer population) and where innovation is rewarded.If Europe is to continue to play a leading role in cancer medicine, it needs greater investment in R&D with an environment that supports and rewards innovation.

Keywords: Pharmaceutical Innovations; Healthcare; Health Systems; Cardiovascular Medicine; Life Sciences; Cancer Medicine; Biopharmaceuticals Sector; Patents; Economic Growth (search for similar items in EconPapers)
Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.worldscientific.com/doi/pdf/10.1142/9789812770974_0003 (application/pdf)
https://www.worldscientific.com/doi/abs/10.1142/9789812770974_0003 (text/html)
Ebook Access is available upon purchase.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wsi:wschap:9789812770974_0003

Ordering information: This item can be ordered from

Access Statistics for this chapter

More chapters in World Scientific Book Chapters from World Scientific Publishing Co. Pte. Ltd.
Bibliographic data for series maintained by Tai Tone Lim ().